Registro:

Referencias:

• Repantis, D., Schlattmann, P., Laisney, O., Heuser, I., Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review (2010) Pharmacol. Res., 62 (3), pp. 187-206
• Maher, B., Poll results: Look who's doping (2008) Nature, 452 (7188), pp. 674-675
• Battleday, R.M., Brem, A.K., Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review (2015) Eur. Neuropsychopharmacol., 25 (11), pp. 1865-1881
• Bromberg-Martin, E.S., Matsumoto, M., Hikosaka, O., Dopamine in motivational control: Rewarding, aversive, and alerting (2010) Neuron, 68 (5), pp. 815-834
• Goldstein, R.Z., Volkow, N.D., Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications (2011) Nat. Rev. Neurosci., 12 (11), pp. 652-669
• Minzenberg, M.J., Carter, C.S., Modafinil: A review of neurochemical actions and effects on cognition (2008) Neuropsychopharmacology, 33 (7), pp. 1477-1502
• Mere, M., Bonci, A., Newman, A.H., Tanda, G., The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders (2013) Psychopharmacology (Berlin), 229 (3), pp. 415-434
• Zolkowska, D., Jain, R., Rothman, R.B., Partilla, J.S., Roth, B.L., Setola, V., Prisinzano, T.E., Baumann, M.H., Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil (2009) J. Pharmacol. Exp. Ther., 329 (2), pp. 738-746
• Madras, B.K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., Johnson, R., Fischman, A.J., Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro (2006) J. Pharmacol. Exp. Ther., 319 (2), pp. 561-569
• Scoriels, L., Jones, P.B., Sahakian, B.J., Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain (2013) Neuropharmacology, 64, pp. 168-184
• Urbano, F.J., Leznik, E., Llinás, R.R., Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling (2007) Proc. Natl. Acad. Sci. U. S. A, 104, pp. 12554-12559
• Raineri, M., Peskin, V., Goitia, B., Taravini, I.R., Giorgeri, S., Urbano, F.J., Bisagno, V., Attenuated methamphetamine induced neu- rotoxicity by modafinil administration in mice (2011) Synapse, 65 (10), pp. 1087-1098
• Raineri, M., Gonzalez, B., Goitia, B., Garcia-Rill, E., Krasnova, I.N., Cadet, J.L., Urbano, F.J., Bisagno, V., Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum (2012) PLoS One, 7 (10), p. e46599
• Lindenmayer, J.P., Nasrallah, H., Pucci, M., James, S., Citrome, L., A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: Challenges and therapeutic opportunities (2013) Schizophr. Res., 147 (2-3), pp. 241-252
• Gruber, O., Chadha Santuccione, A., Aach, H., Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system (2014) Front. Psychiatry, 5, p. 32
• Andrade, C., Kisely, S., Monteiro, I., Rao, S., Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: Systematic review and meta-analysis of randomized controlled trials (2015) J. Psychiatr. Res., 60, pp. 14-21
• Wood, S., Sage, J.R., Shuman, T., Anagnostaras, S.G., Psychostimulants and cognition: A continuum of behavioral and cognitive activation (2013) Pharmacol. Rev., 66 (1), pp. 193-221
• Faraone, S.V., Biederman, J., Spencer, T., Mick, E., Murray, K., Petty, C., Adamson, J.J., Monuteaux, M.C., Diagnosing adult attention deficit hyperactivity disorder: Are late onset and subthreshold diagnoses valid? (2006) Am. J. Psychiatry, 163 (10), pp. 1720-1729
• Biederman, J., Faraone, S.V., The effects of attention-deficit/hyperactivity disorder on employment and household income (2006) Med. Gen. Med., 8 (3), p. 12
• Kooij, S.J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P.J., Edvinsson, D., Ginsberg, Y., European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) BMC Psychiatry, 10, p. 67
• Engert, V., Pruessner, J.C., Dopaminergic and noradrenergic contributions to functionality in ADHD: The role of methylphenidate (2008) Curr. Neuropharmacol., 6 (4), pp. 322-328
• Kuczenski, R., Segal, D.S., Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine (1997) J. Neurochem., 68 (5), pp. 2032-2037
• Markowitz, J.S., DeVane, C.L., Pestreich, L.K., Patrick, K.S., Muniz, R.A., Comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: An exploratory study (2006) J. Child Adolesc. Psychopharmacol., 16 (6), pp. 687-698
• Sandoval, V., Riddle, E.L., Hanson, G.R., Fleckenstein, A.E., Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits (2003) J. Pharmacol. Exp. Ther., 304 (3), pp. 1181-1187
• Volkow, N.D., Wang, G.J., Ma, Y., Fowler, J.S., Wong, C., Ding, Y.S., Hitzemann, R., Kalivas, P., Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: Relevance to addiction (2005) J. Neurosci., 25 (15), pp. 3932-3939
• Fowler, J.S., Volkow, N.D., Logan, J., Alexoff, D., Telang, F., Wang, G.J., Wong, C., Apelskog, K., Fast uptake and long-lasting binding of methamphetamine in the human brain: Comparison with cocaine (2008) Neuroimage, 43 (4), pp. 756-763
• Bright, G.M., Abuse of medications employed for the treatment of ADHD: Results from a large-scale community survey (2008) Medscape J. Med., 10 (5), p. 111
• Frauger, E., Amaslidou, D., Spadari, M., Allaria-Lapierre, V., Braunstein, D., Sciortino, V., Thirion, X., Micallef, J., Patterns of methylphenidate use and assessment of its abuse among the general population and individuals with drug dependence (2016) Eur. Addict. Res., 22 (3), pp. 119-126
• Humphreys, K.L., Eng, T., Lee, S.S., Stimulant medication and substance use outcomes: A meta-analysis (2013) JAMA Psychiatry, 70 (7), pp. 740-749
• Dalsgaard, S., Mortensen, P.B., Frydenberg, M., Thomsen, P.H., ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - A naturalistic long-term follow-up study (2014) Addict. Behav., 39 (1), pp. 325-328
• Breyer, J.L., Lee, S., Winters, K.C., August, G.J., Realmuto, G.M., A longitudinal study of childhood ADHD and substance dependence disorders in early adulthood (2014) Psychol. Addict. Behav., 28 (1), pp. 238-246
• Jasinski, D.R., An evaluation of the abuse potential of modafinil using methylphenidate as a reference (2000) J. Psychopharmacol., 14 (1), pp. 53-60
• Rush, C.R., Kelly, T.H., Hays, L.R., Wooten, A.F., Discriminative-stimulus effects of modafinil in cocaine-trained humans (2002) Drug Alcohol Depend., 67 (3), pp. 311-322
• Volkow, N.D., Wang, G.J., Fowler, J.S., Tomasi, D., Addiction circuitry in the human brain (2012) Annu. Rev. Pharmacol. Toxicol., 52, pp. 321-336
• Cadet, J.L., Bisagno, V., Milroy, C.M., Neuropathology of substance use disorders (2014) Acta Neuropathol., 127, pp. 91-107
• Rice, M.E., Cragg, S.J., Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathway (2008) Brain Res. Rev., 58, pp. 303-313
• Ross, S.B., Renyi, A.L., Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue (1969) Eur. J. Pharmacol., 7 (3), pp. 270-277
• Wilson, M.C., Bedford, J.A., Buelke, J., Kibbe, A.H., Acute pharmacological activity of intravenous cocaine in the rhesus monkey (1976) Psychopharmacol. Commun., 2, pp. 251-261
• Baumann, M.H., Rothman, R.B., Chronic cocaine exposure potentiates prolactin and head shake responses to 5-HT2 receptor stimulation in rats (1996) Neuropharmacology, 35 (3), pp. 295-301
• Filip, M., Nowak, E., Papla, I., On the role of serotonin2A/2C receptors in the sensitization to cocaine (2001) J. Physiol. Pharmacol., 52 (3), pp. 471-481
• Fletcher, P.J., Grottick, A.J., Higgins, G.A., Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding (2002) Neuropsychopharmacology, 27 (4), pp. 576-586
• Burmeister, J.J., Lungren, E.M., Kirschner, K.F., Neisewander, J.L., Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats (2004) Neuropsychopharmacology, 29 (4), pp. 660-668
• Huang, C.C., Liang, Y.C., Lee, C.C., Wu, M.Y., Hsu, K.S., Repeated cocaine administration decreases 5-HT(2A) receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex (2009) Neuropsychopharmacology, 34 (8), pp. 1979-1992
• Goitia, B., Raineri, M., González, L.E., Rozas, J.L., Garcia-Rill, E., Bisagno, V., Urbano, F.J., Differential effects of methylphenidate and cocaine on GABA transmission in sensory thalamic nuclei (2013) J. Neurochem., 124 (5), pp. 602-612
• Goitia, B., Rivero-Echeto, M.C., Weisstaub, N.V., Gingrich, J.A., Garcia-Rill, E., Bisagno, V., Urbano, F.J., Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: Role of serotonin receptors (2016) J. Neurochem., 136 (3), pp. 526-535
• Sulzer, D., Rayport, S., Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action (1990) Neuron, 5 (6), pp. 797-808
• Sulzer, D., Sonders, M.S., Poulsen, N.W., Galli, A., Mechanisms of neurotransmitter release by amphetamines: A review (2005) Prog. Neurobiol., 75 (6), pp. 406-433
• Johnson, M., Sonsalla, P.K., Letter, A.A., Hanson, G.R., Gibb, J.W., Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations (1994) J. Pharmacol. Exp. Ther., 270 (1), pp. 97-103
• Berger, U.V., Gu, X.F., Azmitia, E.C., The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine (1992) Eur. J. Pharmacol., 215 (2-3), pp. 153-160
• Di Chiara, G., Imperato, A., Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats (1988) Proc. Natl. Acad. Sci. U. S. A., 85 (14), pp. 5274-5278
• Hyman, S.E., Addiction: A disease of learning and memory (2005) Am. J. Psychiatry, 162 (8), pp. 1414-1422
• Gamo, N.J., Lur, G., Higley, M.J., Wang, M., Paspalas, C.D., Vijayraghavan, S., Yang, Y., Arnsten, A.F., Stress impairs prefrontal cortical function via D1 dopamine receptor interactions with hyperpolarization-activated cyclic nucleotide-gated channels (2015) Biol. Psychiatry, 78 (12), pp. 860-870
• Wise, R.A., Drive incentive, and reinforcement: The antecedents and consequences of motivation (2004) Neb. Symp. Motiv., 50, pp. 159-195
• Wise, R.A., Dual roles of dopamine in food and drug seeking: The drive-reward paradox (2013) Biol. Psychiatry, 73 (9), pp. 819-826
• Berridge, K.C., Robinson, T.E., What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? (1998) Brain Res. Rev., 28 (3), pp. 309-369
• Berridge, K.C., Kringelbach, M.L., Pleasure systems in the brain (2015) Neuron, 86 (3), pp. 646-664
• Schultz, W., Multiple dopamine functions at different time courses (2007) Annu. Rev. Neurosci., 30, pp. 259-288
• Grace, A.A., Floresco, S.B., Goto, Y., Lodge, D.J., Regulation of firing of dopaminergic neurons and control of goal-directed behaviors (2007) Trends Neurosci., 30 (5), pp. 220-227
• Barchas, J.D., Akil, H., Elliott, G.R., Holman, R.B., Watson, S.J., Behavioral neurochemistry: Neuroregulators and behavioral states (1978) Science, 200 (4344), pp. 964-973
• Cragg, S.J., Nicholson, C., Kume-Kick, J., Tao, L., Rice, M.E., Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake (2001) J. Neurophysiol., 85 (4), pp. 1761-1771
• Rice, M.E., Patel, J.C., Somatodendritic dopamine release: Recent mechanistic insights (2015) Philos. Trans. R. Soc. Lond. B. Biol. Sci., 370 (1672). , pii: 20140185
• Tritsch, N.X., Sabatini, B.L., Dopaminergic modulation of synaptic transmission in cortex and striatum (2012) Neuron, 76 (1), pp. 33-50
• Beaulieu, J.M., Gainetdinov, R.R., The physiology, signaling, and pharmacology of dopamine receptors (2011) Pharmacol. Rev., 63 (1), pp. 182-217
• Felder, C.C., Jose, P.A., Axelrod, J., The dopamine-1 agonist SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase (1989) J. Pharmacol. Exp. Ther., 248, pp. 171-175
• Friedman, E., Jin, L.Q., Cai, G.P., Hollon, T.R., Drago, J., Sibley, D.R., Wang, H.Y., D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: Evidence from D1A knockout mice (1997) Mol. Pharmacol., 51 (1), pp. 6-11
• Sahu, A., Tyeryar, K.R., Vongtau, H.O., Sibley, D.R., Undieh, A.S., D5 dopamine receptors are required for dopaminergic activation of phospholipase C (2009) Mol. Pharmacol., 75, pp. 447-453
• Lee, S.P., So, C.H., Rashid, A.J., Varghese, G., Cheng, R., Lança, A.J., O'Dowd, B.F., George, S.R., Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal (2004) J. Biol. Chem., 279, pp. 35671-35678
• Rashid, A.J., So, C.H., Kong, M.M., Furtak, T., El-Ghundi, M., Cheng, R., O'Dowd, B.F., George, S.R., D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum (2007) Proc. Natl. Acad. Sci. U. S. A., 104 (2), pp. 654-659
• De Mei, C., Ramos, M., Iitaka, C., Borrelli, E., Getting specialized: Presynaptic and postsynaptic dopamine D2 receptors (2009) Curr. Opin. Pharmacol., 9 (1), pp. 53-58
• Sokoloff, P., Diaz, J., Le Foll, B., Guillin, O., Leriche, L., Bezard, E., Gross, C., The dopamine D3 receptor: A therapeutic target for the treatment of neuropsychiatric disorders (2006) CNS Neurol. Disord. Drug Targets, 5 (1), pp. 25-43
• Bentivoglio, M., Morelli, M., The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain (2005) Dopamine, pp. 1-107. , S.B. Dunnett, M. Bentivoglio, A. Bjorklund, T. Hokfelt, Elsevier San Diego, CA
• Goldman-Rakic, P.S., Castner, S.A., Svensson, T.H., Siever, L.J., Williams, G.V., Targeting the dopamine D1 receptor in schizophrenia: Insights for cognitive dysfunction (2004) Psychopharmacology (Berlin), 174 (1), pp. 3-16
• Lidow, M.S., Goldman-Rakic, P.S., Gallager, D.W., Rakic, P., Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using 3H raclopride, 3H spiperone and 3H SCH23390 (1991) Neuroscience, 40, pp. 657-671
• Bergson, C., Mrzljak, L., Smiley, J.F., Pappy, M., Levenson, R., Goldman-Rakic, P.S., Regional cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain (1995) J. Neurosci., 15, pp. 7821-7836
• Muly, E.C., 3rd, Szigeti, K., Goldman-Rakic, P.S., D1 receptor in interneurons of macaque prefrontal cortex: Distribution and subcellular localization (1998) J. Neurosci., 18, pp. 10553-10565
• Liu, F., Wan, Q., Pristupa, Z.B., Yu, X.M., Wang, Y.T., Niznik, H.B., Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors (2000) Nature, 403 (6767), pp. 274-280
• Gao, W.J., Krimer, L.S., Goldman-Rakic, P.S., Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits (2001) Proc. Natl. Acad. Sci. U.S.A., 98, pp. 295-300
• Seamans, J.K., Durstewitz, D., Christie, B.R., Stevens, C.F., Sejnowski, T.J., Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer v prefrontal cortex neurons (2001) Proc. Natl. Acad. Sci. U.S.A., 98, pp. 301-306
• Mrzljak, L., Bergson, C., Pappy, M., Huff, R., Levenson, R., Goldman-Rakic, P.S., Localization of dopamine D4 receptors in GABAergic neurons of the primate brain (1996) Nature, 381, pp. 245-248
• Yao, W.D., Spealman, R.D., Zhang, J., Dopaminergic signaling in dendritic spines (2008) Biochem. Pharmacol., 75 (11), pp. 2055-2069
• Goldman-Rakic, P.S., Leranth, C., Williams, S.M., Mons, N., Geffard, M., Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex (1989) Proc. Natl. Acad. Sci. U.S.A., 86 (22), pp. 9015-9019
• Larkum, M.E., Zhu, J.J., Sakmann, B., A new cellular mechanism for coupling inputs arriving at different cortical layers (1999) Nature, 398 (6725), pp. 338-341
• Seamans, J.K., Durstewitz, D., Christie, B.R., Stevens, C.F., Sejnowski, T.J., Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer v prefrontal cortex neurons (2001) Proc. Natl. Acad. Sci. U.S.A., 98, pp. 301-306
• Gonzalez-Islas, C., Hablitz, J.J., Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex (2003) J. Neurosci., 23, pp. 867-875
• Sun, X., Zhao, Y., Wolf, M.E., Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons (2005) J. Neurosci., 25, pp. 7342-7351
• Gao, C., Wolf, M.E., Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons (2008) J. Neurochem., 106, pp. 2489-2501
• Gurden, H., Takita, M., Jay, T.M., Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo (2000) J. Neurosci., 20, p. RC106
• Huang, Y.Y., Simpson, E., Kellendonk, C., Kandel, E.R., Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors (2004) Proc. Natl. Acad. Sci. U.S.A., 101, pp. 3236-3241
• Cepeda, C., Levine, M.S., Where do you think you are going? the NMDA-D1 receptor trap (2006) Sci. STKE, (333). , pe. 20
• Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634
• Bozzi, Y., Borrelli, E., Dopamine in neurotoxicity and neuroprotection: What do D2 receptors have to do with it (2006) Trends Neurosci., 29, pp. 167-174
• Llinás, R., Moreno, H., Local Ca2+ signaling in neurons (1998) Cell Calcium, 24 (5-6), pp. 359-366
• Kawamoto, E.M., Vivar, C., Camandola, S., Physiology and pathology of calcium signaling in the brain (2012) Front. Pharmacol., 3, pp. 1-17
• Young, C.E., Yang, C.R., Dopamine D1/D5 receptor modulates state-dependent switching of soma-dendritic Ca2+ potentials via differential protein kinase A and C activation in rat prefrontal cortical neurons (2004) J. Neurosci., 24 (1), pp. 8-23
• Kisilevsky, A.E., Mulligan, S.J., Altier, C., Iftinca, M.C., Varela, D., Tai, C., Chen, L., Zamponi, G.W., D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry (2008) Neuron, 58, pp. 557-570
• Tedford, H.W., Zamponi, G.W., Direct G protein modulation of Cav2 calcium channels (2006) Pharmacol. Rev., 58 (4), pp. 837-862
• Dolphin, A.C., G protein modulation of voltage-gated calcium channels (2003) Pharmacol. Rev., 55 (4), pp. 607-627
• Chen, Y., Yu, F.H., Surmeier, D.J., Scheuer, T., Catterall, W.A., Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C (2006) Neuron, 49, pp. 409-420
• Yang, C.R., Seamans, J.S., Dopamine D1 receptor actions in layer V-VI rat prefrontal cortex neurons in vitro: Modulation of dendritic-somatic signal integration (1996) J. Neurosci., 16, pp. 1922-1935
• Kroener, S., Chandler, L.J., Phillips, P.E., Seamans, J.K., Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex (2009) PLoS One, 4 (8), p. e6507
• Vijayraghavan, S., Wang, M., Birnbaum, S.G., Williams, G.V., Arnsten, A.F., Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory (2007) Nat. Neurosci., 10 (3), pp. 376-384
• He, C., Chen, F., Li, B., Hu, Z., Neurophysiology of HCN channels: From cellular functions to multiple regulations (2014) Prog. Neurobiol., 112, pp. 1-23
• Wang, M., Ramos, B.P., Paspalas, C.D., Shu, Y., Simen, A., Duque, A., Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex (2007) Cell, 129, pp. 397-410
• Chen, S., Wang, J., Siegelbaum, S.A., Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide (2001) J. Gen. Physiol., 117, pp. 491-504
• Ulens, C., Tytgat, J., Functional heteromerization of HCN1 and HCN2 pacemaker channels (2001) J. Biol. Chem., 276, pp. 6069-6072
• Notomi, T., Shigemoto, R., Immunohistochemical localization of Ih channel subunits HCN1-4, in the rat brain (2004) J. Comp. Neurol., 471, pp. 241-276
• Santos-Vera, B., Vázquez-Torres, R., Marrero, H.G., Acevedo, J.M., Arencibia-Albite, F., Vélez-Hernández, M.E., Miranda, J.D., Jiménez-Rivera, C.A., Cocaine sensitization increases Ih current channel subunit 2 (HCN2) protein expression in structures of the mesocorticolimbic system (2013) J. Mol. Neurosci., 50, pp. 234-245
• Santoro, B., Chen, S., Luthi, A., Pavlidis, P., Shumyatsky, G.P., Tibbs, G.R., Siegelbaum, S.A., Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS (2000) J. Neurosci., 20, pp. 5264-5275
• Lörincz, A., Notomi, T., Tamás, G., Shigemoto, R., Nusser, Z., Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites (2002) Nat. Neurosci., 5, pp. 1185-1193
• Berger, T., Senn, W., Lüscher, H.R., Hyperpolarization-activated current Ih disconnects somatic and dendritic spike initiation zones in layer v pyramidal neurons (2003) J. Neurophysiol., 90 (4), pp. 2428-2437
• Wu, J., Hablitz, J.J., Cooperative activation of D1 and D2 dopamine receptors enhances a hyperpolarization-activated inward current in layer i interneurons (2005) J. Neurosci., 25 (27), pp. 6322-6328
• Arnsten, A.F., Prefrontal cortical network connections: Key site of vulnerability in stress and schizophrenia (2011) Int. J. Dev. Neurosci., 29, pp. 215-223
• Nolan, M.F., Malleret, G., Dudman, J.T., Buhl, D.L., Santoro, B., Gibbs, E., Vronskaya, S., Morozov, A., A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons (2004) Cell, 119, pp. 719-732
• Magee, J.C., Dendritic lh normalizes temporal summation in hippocampal CA1 neurons (1999) Nat. Neurosci., 2, pp. 508-514
• Rotaru, D.C., Lewis, D.A., Gonzalez-Burgos, G., Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons (2007) J. Physiol., 581, pp. 981-1000
• Gorelova, N., Seamans, J.K., Yang, C.R., Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex (2002) J. Neurophysiol., 88 (6), pp. 3150-3166
• Dong, Y., Cooper, D., Nasif, F., Hu, X.T., White, F.J., Dopamine modulates inwardly rectifying potassium currents in medial prefrontal cortex pyramidal neurons (2004) J. Neurosci., 24 (12), pp. 3077-3085
• Witkowski, G., Szulczyk, B., Rola, R., Szulczyk, P., D(1) dopaminergic control of G protein-dependent inward rectifier K(+) (GIRK)-like channel current in pyramidal neurons of the medial prefrontal cortex (2008) Neuroscience, 155 (1), pp. 53-63
• Maurice, N., Tkatch, T., Meisler, M., Sprunger, L.K., Surmeier, D.J., D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons (2001) J. Neurosci., 21 (7), pp. 2268-2277
• Peterson, J.D., Wolf, M.E., White, F.J., Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex (2006) J. Neurosci., 26, pp. 3164-3168
• Franceschetti, S., Taverna, S., Sancini, G., Panzica, F., Lombardi, R., Avanzini, G., Protein kinase C-dependent modulation of Na+ currents increases the excitability of rat neocortical pyramidal neurones (2000) J. Physiol., 528, pp. 291-304
• Goldman-Rakic, P.S., Muly, E.C., III, Williams, G.V., D(1) receptors in prefrontal cells and circuits (2000) Brain Res. Brain Res. Rev., 31 (2-3), pp. 295-301
• Goldman-Rakic, P.S., Castner, S.A., Svensson, T.H., Siever, L.J., Williams, G.V., Targeting the dopamine D1 receptor in schizophrenia: Insights for cognitive dysfunction (2004) Psychopharmacology (Berlin), 174 (1), pp. 3-16
• De Jongh, R., Bolt, I., Schermer, M., Oliver, B., Botox for the brain: Enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories (2008) Neurosci. Biobehav. Rev., 32 (4), pp. 760-776
• Lin, G.L., Borders, C.B., Lundewall, L.J., Wellman, C.L., D1 receptors regulate dendritic morphology in normal and stressed prelimbic cortex (2015) Psychoneuroendocrinology, 51, pp. 101-111
• Mair, R.D., Kauer, J.A., Amphetamine depresses excitatory synaptic transmission at prefrontal cortical layer v synapses (2007) Neuropharmacology, 52, pp. 193-199
• Berridge, C.W., Devilbiss, D.M., Andrzejewski, M.E., Arnsten, A.F., Kelley, A.E., Schmeichel, B., Hamilton, C., Spencer, R.C., Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function (2006) Biol. Psychiatry, 60 (10), pp. 1111-1120
• Andrews, G.D., Lavin, A., Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors (2006) Neuropsychopharmacology, 31 (3), pp. 594-601
• Devilbiss, D.M., Berridge, C.W., Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness (2008) Biol. Psychiatry, 64 (7), pp. 626-635
• Urban, K.R., Waterhouse, B.D., Gao, W.J., Distinct age-dependent effects of methylphenidate on developing and adult prefrontal neurons (2012) Biol. Psychiatry, 72 (10), pp. 880-888
• Joo, E.Y., Tae, W.S., Jung, K.Y., Hong, S.B., Cerebral blood flow changes in man by wake-promoting drug, modafinil: A randomized double blind study (2008) J. Sleep Res., 17 (1), pp. 82-88
• Saletu, M., Anderer, P., Semlitsch, H.V., Saletu-Zyhlarz, G.M., Mandl, M., Zeitlhofer, J., Saletu, B., Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy (2007) Psychiatry Res., 154 (1), pp. 69-84
• Hunter, M.D., Ganesan, V., Wilkinson, I.D., Spence, S.A., Impact of modafinil on prefrontal executive function in schizophrenia (2006) Am. J. Psychiatry, 163 (12), pp. 2184-2186
• Spence, S.A., Green, R.D., Wilkinson, I.D., Hunter, M.D., Modafinil modulates anterior cingulate function in chronic schizophrenia (2005) Br. J. Psychiatry, 187, pp. 55-61
• Gozzi, A., Colavito, V., Seke Etet, P.F., Montanari, D., Fiorini, S., Tambalo, S., Bifone, A., Bentivoglio, M., Modulation of fronto-cortical activity by modafinil: A functional imaging and fos study in the rat (2012) Neuropsychopharmacology, 37 (3), pp. 822-837
• Minzenberg, M.J., Carter, C.S., Modafinil: A review of neurochemical actions and effects on cognition (2008) Neuropsychopharmacology, 33 (7), pp. 1477-1502
• Rowley, H.L., Kulkarni, R.S., Gosden, J., Brammer, R.J., Hackett, D., Heal, D.J., Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats (2014) J. Psychopharmacol., 28 (3), pp. 254-269
• Gonzalez, B., Raineri, M., Cadet, J.L., Garcia-Rill, E., Urbano, F.J., Bisagno, V., Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice (2014) Neuropharmacology, 87, pp. 188-197
• Kamei, H., Nagai, T., Nakano, H., Togan, Y., Takayanagi, M., Takahashi, K., Kobayashi, K., Yamada, K., Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice (2006) Biol. Psychiatry, 59, pp. 75-84
• Nagai, T., Takuma, K., Dohniwa, M., Ibi, D., Mizoguchi, H., Kamei, H., Nabeshima, T., Yamada, K., Repeated methamphetamine treatment impairs spatial working memory in rats: Reversal by clozapine but not haloperidol (2007) Psychopharmacology (Berlin), 194 (1), pp. 21-32
• Valjent, E., Corvol, J.C., Pages, C., Besson, M.J., Maldonado, R., Caboche, J., Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties (2000) J. Neurosci., 20 (23), pp. 8701-8709
• Young, J.W., Geyer, M.A., Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors? (2010) Biol. Psychiatry, 67 (8), pp. 784-787
• Cadet, J.L., Bisagno, V., Neuropsychological consequences of chronic drug use: Relevance to treatment approaches (2016) Front. Psychiatry, 6, p. 189
• Tomasi, D., Goldstein, R.Z., Telang, F., Maloney, T., Alia-Klein, N., Caparelli, E.C., Volkow, N.D., Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence (2007) Brain Res., 1171, pp. 83-92
• Goldstein, R.Z., Leskovjan, A.C., Hoff, A.L., Hitzemann, R., Bashan, F., Khalsa, S.S., Wang, G.J., Volkow, N.D., Severity of neuropsychological impairment in cocaine and alcohol addiction: Association with metabolism in the prefrontal cortex (2004) Neuropsychologia, 42 (11), pp. 1447-1458
• Camchong, J., MacDonald, A.W., 3rd, Nelson, B., Bell, C., Mueller, B.A., Specker, S., Lim, K.O., Frontal hyperconnectivity related to discounting and reversal learning in cocaine subjects (2011) Biol. Psychiatry, 69 (11), pp. 1117-1123
• Barrós-Loscertales, A., Bustamante, J.C., Ventura-Campos, N., Llopis, J.J., Parcet, M.A., Avila, C., Lower activation in the right frontoparietal network during a counting Stroop task in a cocaine-dependent group (2011) Psychiatry Res., 194 (2), pp. 111-118
• Bolla, K.I., Eldreth, D.A., London, E.D., Kiehl, K.A., Mouratidis, M., Contoreggi, C., Matochik, J.A., Ernst, M., Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task (2003) Neuroimage, 19 (3), pp. 1085-1094
• Bechara, A., The role of emotion in decision-making: Evidence from neurological patients with orbitofrontal damage (2004) Brain Cogn., 55 (1), pp. 30-40
• Chen, B.T., Yau, H.J., Hatch, C., Kusumoto-Yoshida, I., Cho, S.L., Hopf, F.W., Bonci, A., Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking (2013) Nature, 496 (7445), pp. 359-362
• Wayman, W.N., Chen, L., Napier, T.C., Hu, X.T., Cocaine self-administration enhances excitatory responses of pyramidal neurons in the rat medial prefrontal cortex to human immunodeficiency virus-1 Tat (2015) Eur. J. Neurosci., 41 (9), pp. 1195-1206
• Paulus, M.P., Hozack, N.E., Zauscher, B.E., Frank, L., Brown, G.G., Braff, D.L., Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects (2002) Neuropsychopharmacology, 26, pp. 53-63
• Chang, L., Cloak, C., Patterson, K., Grob, C., Miller, E.N., Ernst, T., Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response (2005) Biol. Psychiatry, 57, pp. 967-974
• London, E.D., Berman, S.M., Voytek, B., Simon, S.L., Mandelkern, M.A., Monterosso, J., Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers (2005) Biol. Psychiatry, 58, pp. 770-778
• Johanson, C.-E., Frey, K.A., Lundahl, L.H., Keenan, P., Lockhart, N., Roll, J., Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers (2006) Psychopharmacology, 185, pp. 327-338
• Monterosso, J.R., Ainslie, G., Xu, J., Cordova, X., Domier, C.P., London, E.D., Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task (2007) Hum. Brain Mapp., 28, pp. 383-393
• Hoffman, W.F., Moore, M., Templin, R., McFarland, B., Hitzemann, R.J., Mitchell, S.H., Neuropsychological function and delay discounting in methamphetamine-dependent individuals (2006) Psychopharmacology, 188, pp. 162-170
• Nestor, L.J., Ghahremani, D.G., Monterosso, J., London, E.D., Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects (2011) Psychiatry Res., 194, pp. 287-295
• Parsegian, A., See, R.E., Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats (2014) Neuropsychopharmacology, 39, pp. 811-822
• Salo, R., Ursu, S., Buonocore, M.H., Leamon, M.H., Carter, C., Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: A functional magnetic resonance imaging study (2009) Biol. Psychiatry, 65, pp. 706-709
• González, B., Rivero-Echeto, C., Muñiz, J.L., García-Rill, F.J., Bisagno, V., Methamphetamine blunts Ca2+ currents and excitatory synaptic transmission through D1 /5 receptor-mediated mechanisms in the mouse medial prefrontal cortex (2015) Addict. Biol., , (in press)
• Zhou, W.L., Antic, S.D., Rapid dopaminergic and GABAergic modulation of calcium and voltage transients in dendrites of prefrontal cortex pyramidal neurons (2012) J. Physiol., 590, pp. 3891-3911
• Dürsteler, K.M., Berger, E.M., Strasser, J., Caflisch, C., Mutschler, J., Herdener, M., Vogel, M., Clinical potential of methylphenidate in the treatment of cocaine addiction: A review of the current evidence (2016) Subst. Abuse Rehabil., , (in press)
• Pérez-Mañá, C., Castells, X., Torrens, M., Capellà, D., Farre, M., Efficacy of psychostimulant drugs for amphetamine abuse or dependence (2013) Cochrane Database Syst. Rev., 9, p. CD009695
• Castells, X., Casas, M., Pérez-Mañá, C., Roncero, C., Vidal, X., Capellà, D., Efficacy of psychostimulant drugs for cocaine dependence (2010) Cochrane Database Syst Rev., 2, p. CD007380

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------